{
  "ticker": "LH",
  "last_updated": "2025-04-15T16:12:15.965878",
  "retention_years": 3,
  "count": 294,
  "transactions": [
    {
      "id": 183917,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2023-12-15",
      "transaction_shares": "64",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3373.5491"
    },
    {
      "id": 183873,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-11-16",
      "transaction_shares": "1384",
      "transaction_price": "210.713",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 133822,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-12",
      "transaction_shares": "372",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "372"
    },
    {
      "id": 183954,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-12",
      "transaction_shares": "372",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "372"
    },
    {
      "id": 133802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-08",
      "transaction_shares": "5000",
      "transaction_price": "211.5665",
      "transaction_type": "S",
      "shares_after_transaction": "15275"
    },
    {
      "id": 183934,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-08",
      "transaction_shares": "5000",
      "transaction_price": "211.5665",
      "transaction_type": "S",
      "shares_after_transaction": "15275"
    },
    {
      "id": 133764,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-08-01",
      "transaction_shares": "56",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3488.2194"
    },
    {
      "id": 183895,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-08-01",
      "transaction_shares": "56",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3488.2194"
    },
    {
      "id": 90087,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-06-29",
      "transaction_shares": "212",
      "transaction_price": "240.00",
      "transaction_type": "S",
      "shares_after_transaction": "7604.6975"
    },
    {
      "id": 133788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-06-29",
      "transaction_shares": "212",
      "transaction_price": "240.00",
      "transaction_type": "S",
      "shares_after_transaction": "7604.6975"
    },
    {
      "id": 183920,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-06-29",
      "transaction_shares": "212",
      "transaction_price": "240.00",
      "transaction_type": "S",
      "shares_after_transaction": "7604.6975"
    },
    {
      "id": 90049,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-05-19",
      "transaction_shares": "4300",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17246"
    },
    {
      "id": 133749,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-05-19",
      "transaction_shares": "4300",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17246"
    },
    {
      "id": 183880,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-05-19",
      "transaction_shares": "4300",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17246"
    },
    {
      "id": 90042,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2023-05-18",
      "transaction_shares": "1500",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "8187.4022"
    },
    {
      "id": 133742,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2023-05-18",
      "transaction_shares": "1500",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "8187.4022"
    },
    {
      "id": 183872,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2023-05-18",
      "transaction_shares": "1500",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "8187.4022"
    },
    {
      "id": 53848,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3234",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4903"
    },
    {
      "id": 53856,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3381",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5345.9485"
    },
    {
      "id": 53857,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "42353",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 53865,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-03-30",
      "transaction_shares": "11715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47355"
    },
    {
      "id": 53870,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3609",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9161.7592"
    },
    {
      "id": 53883,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13450.4022"
    },
    {
      "id": 53895,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23175.7624"
    },
    {
      "id": 53896,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "1798",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3958.2194"
    },
    {
      "id": 53898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15832"
    },
    {
      "id": 53909,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "4509",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24677"
    },
    {
      "id": 90048,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3234",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4903"
    },
    {
      "id": 90061,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3381",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5345.9485"
    },
    {
      "id": 90062,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "42353",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 90071,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-03-30",
      "transaction_shares": "11715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47355"
    },
    {
      "id": 90076,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3609",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9161.7592"
    },
    {
      "id": 90092,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13450.4022"
    },
    {
      "id": 90108,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23175.7624"
    },
    {
      "id": 90109,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "1798",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3958.2194"
    },
    {
      "id": 90111,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15832"
    },
    {
      "id": 90122,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "4509",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24677"
    },
    {
      "id": 133748,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3234",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4903"
    },
    {
      "id": 133761,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3381",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5345.9485"
    },
    {
      "id": 133762,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "42353",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 133772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-03-30",
      "transaction_shares": "11715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47355"
    },
    {
      "id": 133777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3609",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9161.7592"
    },
    {
      "id": 133793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13450.4022"
    },
    {
      "id": 133810,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23175.7624"
    },
    {
      "id": 133811,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "1798",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3958.2194"
    },
    {
      "id": 133813,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15832"
    },
    {
      "id": 133825,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "4509",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24677"
    },
    {
      "id": 183879,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3234",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4903"
    },
    {
      "id": 183892,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3381",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5345.9485"
    },
    {
      "id": 183893,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "42353",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65534"
    },
    {
      "id": 183903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-03-30",
      "transaction_shares": "11715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47355"
    },
    {
      "id": 183908,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "3609",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9161.7592"
    },
    {
      "id": 183925,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13450.4022"
    },
    {
      "id": 183942,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23175.7624"
    },
    {
      "id": 183943,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-03-30",
      "transaction_shares": "1798",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3958.2194"
    },
    {
      "id": 183945,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-03-30",
      "transaction_shares": "6763",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15832"
    },
    {
      "id": 183957,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-03-30",
      "transaction_shares": "4509",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24677"
    },
    {
      "id": 53894,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-02",
      "transaction_shares": "1340",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2043"
    },
    {
      "id": 90107,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-02",
      "transaction_shares": "1340",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2043"
    },
    {
      "id": 133809,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-02",
      "transaction_shares": "1340",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2043"
    },
    {
      "id": 183941,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-03-02",
      "transaction_shares": "1340",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2043"
    },
    {
      "id": 53888,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-21",
      "transaction_shares": "3000",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17069"
    },
    {
      "id": 90100,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-21",
      "transaction_shares": "3000",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17069"
    },
    {
      "id": 133801,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-21",
      "transaction_shares": "3000",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17069"
    },
    {
      "id": 183933,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-21",
      "transaction_shares": "3000",
      "transaction_price": "182.51",
      "transaction_type": "M",
      "shares_after_transaction": "17069"
    },
    {
      "id": 53846,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-14",
      "transaction_shares": "309",
      "transaction_price": "247.63",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 90046,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-14",
      "transaction_shares": "309",
      "transaction_price": "247.63",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 133746,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-14",
      "transaction_shares": "309",
      "transaction_price": "247.63",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 183877,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-14",
      "transaction_shares": "309",
      "transaction_price": "247.63",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53828,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7587"
    },
    {
      "id": 53840,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20253"
    },
    {
      "id": 53849,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-11",
      "transaction_shares": "483",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14211"
    },
    {
      "id": 53851,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7110.4022"
    },
    {
      "id": 53862,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "180",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "757"
    },
    {
      "id": 53868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10951"
    },
    {
      "id": 53872,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5630.7592"
    },
    {
      "id": 53873,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "2656",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "24351"
    },
    {
      "id": 53877,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "236",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2033.9485"
    },
    {
      "id": 53878,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7765"
    },
    {
      "id": 53881,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17004"
    },
    {
      "id": 53882,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20275"
    },
    {
      "id": 53885,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-11",
      "transaction_shares": "723",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35835"
    },
    {
      "id": 53892,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16536.7624"
    },
    {
      "id": 53897,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10996"
    },
    {
      "id": 53899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2672"
    },
    {
      "id": 53900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "110",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2198.2194"
    },
    {
      "id": 53903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7173"
    },
    {
      "id": 53904,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1345"
    },
    {
      "id": 90024,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7587"
    },
    {
      "id": 90038,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20253"
    },
    {
      "id": 90050,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-11",
      "transaction_shares": "483",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14211"
    },
    {
      "id": 90053,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7110.4022"
    },
    {
      "id": 90068,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "180",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "757"
    },
    {
      "id": 90074,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10951"
    },
    {
      "id": 90078,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5630.7592"
    },
    {
      "id": 90079,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "2656",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "24351"
    },
    {
      "id": 90084,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "236",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2033.9485"
    },
    {
      "id": 90086,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7765"
    },
    {
      "id": 90090,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17004"
    },
    {
      "id": 90091,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20275"
    },
    {
      "id": 90094,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-11",
      "transaction_shares": "723",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35835"
    },
    {
      "id": 90105,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16536.7624"
    },
    {
      "id": 90110,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10996"
    },
    {
      "id": 90112,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2672"
    },
    {
      "id": 90113,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "110",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2198.2194"
    },
    {
      "id": 90116,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7173"
    },
    {
      "id": 90117,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1345"
    },
    {
      "id": 133724,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7587"
    },
    {
      "id": 133738,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20253"
    },
    {
      "id": 133750,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-11",
      "transaction_shares": "483",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14211"
    },
    {
      "id": 133753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7110.4022"
    },
    {
      "id": 133769,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "180",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "757"
    },
    {
      "id": 133775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10951"
    },
    {
      "id": 133779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5630.7592"
    },
    {
      "id": 133780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "2656",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "24351"
    },
    {
      "id": 133785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "236",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2033.9485"
    },
    {
      "id": 133787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7765"
    },
    {
      "id": 133791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17004"
    },
    {
      "id": 133792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20275"
    },
    {
      "id": 133795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-11",
      "transaction_shares": "723",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35835"
    },
    {
      "id": 133807,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16536.7624"
    },
    {
      "id": 133812,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10996"
    },
    {
      "id": 133814,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2672"
    },
    {
      "id": 133815,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "110",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2198.2194"
    },
    {
      "id": 133818,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7173"
    },
    {
      "id": 133819,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1345"
    },
    {
      "id": 183854,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7587"
    },
    {
      "id": 183868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20253"
    },
    {
      "id": 183881,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-11",
      "transaction_shares": "483",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14211"
    },
    {
      "id": 183884,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7110.4022"
    },
    {
      "id": 183900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "180",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "757"
    },
    {
      "id": 183906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10951"
    },
    {
      "id": 183910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "290",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5630.7592"
    },
    {
      "id": 183911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "2656",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "24351"
    },
    {
      "id": 183916,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-11",
      "transaction_shares": "236",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2033.9485"
    },
    {
      "id": 183919,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7765"
    },
    {
      "id": 183923,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17004"
    },
    {
      "id": 183924,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20275"
    },
    {
      "id": 183927,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-11",
      "transaction_shares": "723",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35835"
    },
    {
      "id": 183939,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-11",
      "transaction_shares": "423",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16536.7624"
    },
    {
      "id": 183944,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "10996"
    },
    {
      "id": 183946,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2672"
    },
    {
      "id": 183947,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-11",
      "transaction_shares": "110",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2198.2194"
    },
    {
      "id": 183950,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7173"
    },
    {
      "id": 183951,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-11",
      "transaction_shares": "742",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1345"
    },
    {
      "id": 53850,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-07",
      "transaction_shares": "409",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53879,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-07",
      "transaction_shares": "219",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "5340.7592"
    },
    {
      "id": 90052,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-07",
      "transaction_shares": "409",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 90088,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-07",
      "transaction_shares": "219",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "5340.7592"
    },
    {
      "id": 133752,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-07",
      "transaction_shares": "409",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 133789,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-07",
      "transaction_shares": "219",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "5340.7592"
    },
    {
      "id": 183883,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-07",
      "transaction_shares": "409",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 183921,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-07",
      "transaction_shares": "219",
      "transaction_price": "243.01",
      "transaction_type": "S",
      "shares_after_transaction": "5340.7592"
    },
    {
      "id": 53829,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5640.7592"
    },
    {
      "id": 53836,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "150",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2140.2194"
    },
    {
      "id": 53839,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "280",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1881.9485"
    },
    {
      "id": 53841,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "267",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "660"
    },
    {
      "id": 53845,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7247.4022"
    },
    {
      "id": 53853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16277.7624"
    },
    {
      "id": 53861,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-04",
      "transaction_shares": "970",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35373"
    },
    {
      "id": 53884,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13892"
    },
    {
      "id": 53891,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "3507",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23063"
    },
    {
      "id": 53911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "374",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20071"
    },
    {
      "id": 90026,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5640.7592"
    },
    {
      "id": 90034,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "150",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2140.2194"
    },
    {
      "id": 90037,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "280",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1881.9485"
    },
    {
      "id": 90040,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "267",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "660"
    },
    {
      "id": 90045,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7247.4022"
    },
    {
      "id": 90055,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16277.7624"
    },
    {
      "id": 90067,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-04",
      "transaction_shares": "970",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35373"
    },
    {
      "id": 90093,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13892"
    },
    {
      "id": 90104,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "3507",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23063"
    },
    {
      "id": 90125,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "374",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20071"
    },
    {
      "id": 133726,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5640.7592"
    },
    {
      "id": 133734,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "150",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2140.2194"
    },
    {
      "id": 133737,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "280",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1881.9485"
    },
    {
      "id": 133740,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "267",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "660"
    },
    {
      "id": 133745,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7247.4022"
    },
    {
      "id": 133755,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16277.7624"
    },
    {
      "id": 133768,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-04",
      "transaction_shares": "970",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35373"
    },
    {
      "id": 133794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13892"
    },
    {
      "id": 133806,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "3507",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23063"
    },
    {
      "id": 133828,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "374",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20071"
    },
    {
      "id": 183856,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "300",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5640.7592"
    },
    {
      "id": 183864,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "150",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2140.2194"
    },
    {
      "id": 183867,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "280",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1881.9485"
    },
    {
      "id": 183870,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-04",
      "transaction_shares": "267",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "660"
    },
    {
      "id": 183876,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7247.4022"
    },
    {
      "id": 183886,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16277.7624"
    },
    {
      "id": 183899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-04",
      "transaction_shares": "970",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "35373"
    },
    {
      "id": 183926,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-04",
      "transaction_shares": "560",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13892"
    },
    {
      "id": 183938,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "3507",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23063"
    },
    {
      "id": 183960,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-04",
      "transaction_shares": "374",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20071"
    },
    {
      "id": 53843,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-02",
      "transaction_shares": "767",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "34609"
    },
    {
      "id": 53844,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "470"
    },
    {
      "id": 53852,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "237",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5577.7592"
    },
    {
      "id": 53860,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1678.9485"
    },
    {
      "id": 53863,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "117",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2031.2194"
    },
    {
      "id": 53864,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "2773",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20361"
    },
    {
      "id": 53876,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "15861.7624"
    },
    {
      "id": 53887,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13473"
    },
    {
      "id": 53890,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7130.4022"
    },
    {
      "id": 53901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "297",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "19799"
    },
    {
      "id": 90043,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-02",
      "transaction_shares": "767",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "34609"
    },
    {
      "id": 90044,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "470"
    },
    {
      "id": 90054,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "237",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5577.7592"
    },
    {
      "id": 90066,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1678.9485"
    },
    {
      "id": 90069,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "117",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2031.2194"
    },
    {
      "id": 90070,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "2773",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20361"
    },
    {
      "id": 90083,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "15861.7624"
    },
    {
      "id": 90099,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13473"
    },
    {
      "id": 90103,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7130.4022"
    },
    {
      "id": 90114,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "297",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "19799"
    },
    {
      "id": 133743,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-02",
      "transaction_shares": "767",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "34609"
    },
    {
      "id": 133744,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "470"
    },
    {
      "id": 133754,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "237",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5577.7592"
    },
    {
      "id": 133767,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1678.9485"
    },
    {
      "id": 133770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "117",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2031.2194"
    },
    {
      "id": 133771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "2773",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20361"
    },
    {
      "id": 133784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "15861.7624"
    },
    {
      "id": 133800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13473"
    },
    {
      "id": 133805,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7130.4022"
    },
    {
      "id": 133816,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "297",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "19799"
    },
    {
      "id": 183874,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2023-02-02",
      "transaction_shares": "767",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "34609"
    },
    {
      "id": 183875,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "470"
    },
    {
      "id": 183885,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "237",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5577.7592"
    },
    {
      "id": 183898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Seltz Judith C",
      "reporting_owner_cik": "0001791228",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "220",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1678.9485"
    },
    {
      "id": 183901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2023-02-02",
      "transaction_shares": "117",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2031.2194"
    },
    {
      "id": 183902,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "2773",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20361"
    },
    {
      "id": 183915,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "15861.7624"
    },
    {
      "id": 183932,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13473"
    },
    {
      "id": 183937,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2023-02-02",
      "transaction_shares": "443",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7130.4022"
    },
    {
      "id": 183948,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2023-02-02",
      "transaction_shares": "297",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "19799"
    },
    {
      "id": 28662,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 53855,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 90059,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 133759,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 183890,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 28660,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 28661,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 53837,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 53838,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 90035,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 90036,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 133735,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 133736,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 183865,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 183866,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 28656,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 28659,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 28667,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 53827,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 53832,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 53910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 90023,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 90030,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 90123,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 133723,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 133730,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 133826,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 183853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 183860,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 183958,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 12585,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 28663,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 53874,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 90080,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 133781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 183912,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 12587,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 28665,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 53905,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 90118,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 133820,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 183952,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 12589,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 28668,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 53912,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 90126,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 133829,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 183961,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 12588,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 28666,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 53906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 90119,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 133821,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 183953,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 2651,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 12586,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 28664,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 53880,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 90089,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 133790,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 183922,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    }
  ]
}